Mark O’Neill

3.5k total citations · 1 hit paper
13 papers, 2.6k citations indexed

About

Mark O’Neill is a scholar working on Psychiatry and Mental health, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Mark O’Neill has authored 13 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Psychiatry and Mental health, 4 papers in Molecular Biology and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Mark O’Neill's work include Child Nutrition and Feeding Issues (5 papers), Clinical Nutrition and Gastroenterology (4 papers) and Diabetes Treatment and Management (3 papers). Mark O’Neill is often cited by papers focused on Child Nutrition and Feeding Issues (5 papers), Clinical Nutrition and Gastroenterology (4 papers) and Diabetes Treatment and Management (3 papers). Mark O’Neill collaborates with scholars based in United Kingdom, United States and Canada. Mark O’Neill's co-authors include Steven E. Kahn, Bernard Zinman, Steven M. Haffner, Mark Heise, Barbara G. Kravitz, Giancarlo Viberti, Rury R. Holman, William H. Herman, Nigel C. Jones and John M. Lachin and has published in prestigious journals such as New England Journal of Medicine, Diabetes and Clinical Chemistry.

In The Last Decade

Mark O’Neill

12 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy

2006 2.2k citations Steven E. Kahn, Steven M. Haffner et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark O’Neill United Kingdom	9	2.0k	1.3k	807	302	300	13	2.6k
Barbara G. Kravitz United States	15	2.4k 1.2×	1.9k 1.5×	906 1.1×	289 1.0×	389 1.3×	23	3.6k
M. Nauck Germany	3	2.8k 1.4×	1.1k 0.8×	828 1.0×	234 0.8×	309 1.0×	5	3.3k
Søren S. Lund Germany	22	1.5k 0.7×	659 0.5×	635 0.8×	100 0.3×	245 0.8×	50	1.9k
Stanley S. Schwartz United States	21	1.4k 0.7×	671 0.5×	573 0.7×	257 0.9×	337 1.1×	64	2.3k
Teresa Mezza Italy	24	758 0.4×	428 0.3×	694 0.9×	325 1.1×	318 1.1×	74	1.8k
Maria Alba United States	22	2.2k 1.1×	863 0.7×	1.2k 1.5×	260 0.9×	220 0.7×	44	2.5k
Elizabeth Greyber United States	7	1.5k 0.7×	584 0.4×	266 0.3×	581 1.9×	202 0.7×	9	2.0k
John Gerich United States	10	2.5k 1.3×	941 0.7×	937 1.2×	512 1.7×	330 1.1×	11	3.1k
Gian Pio Sorice Italy	22	683 0.3×	399 0.3×	520 0.6×	219 0.7×	359 1.2×	47	1.7k
Martin Ridderstråle Sweden	29	1.4k 0.7×	1.4k 1.1×	615 0.8×	360 1.2×	1.1k 3.7×	84	3.7k

Countries citing papers authored by Mark O’Neill

Since Specialization

Citations

This map shows the geographic impact of Mark O’Neill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark O’Neill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark O’Neill more than expected).

Fields of papers citing papers by Mark O’Neill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark O’Neill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark O’Neill. The network helps show where Mark O’Neill may publish in the future.

Co-authorship network of co-authors of Mark O’Neill

This figure shows the co-authorship network connecting the top 25 collaborators of Mark O’Neill. A scholar is included among the top collaborators of Mark O’Neill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark O’Neill. Mark O’Neill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Fraser, Lorna, André Bedendo, Mark O’Neill, et al.. (2023). ‘YourTube’ the role of different diets in gastrostomy‐fed children: Baseline findings from a prospective cohort study. Developmental Medicine & Child Neurology. 66(6). 755–764. 3 indexed citations

Ziegler, Lucy, Bryony Beresford, Suzanne Mukherjee, et al.. (2023). Psychological well-being of hospice staff: systematic review. BMJ Supportive & Palliative Care. 13(e3). e597–e611. 9 indexed citations

Fraser, Lorna, Mark O’Neill, Julia Hackett, et al.. (2023). 140 ‘YourTube’ the role of different diets in children who are gastrostomy fed. A30.2–A31.

Fraser, Lorna, André Bedendo, Mark O’Neill, et al.. (2023). Safety, resource use and nutritional content of home-blended diets in children who are gastrostomy fed: findings from ‘YourTube’ – a prospective cohort study. Archives of Disease in Childhood. 109(8). 628–635. 2 indexed citations

Taylor, Jo, Mark O’Neill, Janet Cade, et al.. (2021). Outcomes for gastrostomy‐fed children and their parents: qualitative findings from the ‘Your Tube’ study. Developmental Medicine & Child Neurology. 63(9). 1099–1106. 14 indexed citations

Taylor, Jo, Mark O’Neill, Gerry Richardson, et al.. (2019). ‘Your Tube’: the role of different diets in children who are gastrostomy fed: protocol for a mixed methods exploratory sequential study. BMJ Open. 9(10). e033831–e033831. 9 indexed citations

Baker, Claire, Suman Wason, Phillip Banks, et al.. (2019). Dose‐dependent glycometabolic effects of sotagliflozin on type 1 diabetes over 12 weeks: The inTandem4 trial. Diabetes Obesity and Metabolism. 21(11). 2440–2449. 21 indexed citations

Fife‐Schaw, Chris, et al.. (2014). Comparing exercise interventions to increase persistence with physical exercise and sporting activity among people with hypertension or high normal blood pressure: study protocol for a randomised controlled trial. Trials. 15(1). 336–336. 9 indexed citations

Kahn, Steven E., Steven M. Haffner, Mark Heise, et al.. (2006). Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy. New England Journal of Medicine. 355(23). 2427–2443. 2202 indexed citations breakdown →

10.

Kahn, Steven E., Bernard Zinman, Steven M. Haffner, et al.. (2006). Obesity Is a Major Determinant of the Association of C-Reactive Protein Levels and the Metabolic Syndrome in Type 2 Diabetes. Diabetes. 55(8). 2357–2364. 149 indexed citations

11.

Rosenstock, Julio, B. J. Goldstein, A Vinik, et al.. (2005). Effect of early addition of rosiglitazone to sulphonylurea therapy in older type 2 diabetes patients (>60 years): the Rosiglitazone Early vs. SULphonylurea Titration (RESULT) study. Diabetes Obesity and Metabolism. 8(1). 49–57. 52 indexed citations

12.

Zinman, Bernard, Steven E. Kahn, Steven M. Haffner, et al.. (2004). Phenotypic Characteristics of GAD Antibody-Positive Recently Diagnosed Patients With Type 2 Diabetes in North America and Europe. Diabetes. 53(12). 3193–3200. 143 indexed citations

13.

Ng, R H, et al.. (1987). Increased activities of creatine kinase and lactate dehydrogenase isoenzymes in a patient with metastatic ovarian tumor.. Clinical Chemistry. 33(8). 1484–1485. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact